MRI

Catch up on the top radiology content of the past week.

For patients with relapsing multiple sclerosis, switching from oral therapies to subcutaneous monthly administration of the anti-CD20 monoclonal antibody ofatumumab led to over a 98 percent reduction of Gd+ T1 lesions on MRI at 96 weeks.

Catch up on the most-well viewed radiology content in September 2025.

Catch up on the top radiology content of the past week.

Facilitating increased efficiency in radiation therapy planning, the new Rembra RT and Areta RT computed tomography platforms reportedly offer 4D CT capabilities and image reconstruction speeds up to 106 images per second.

Emphasizing enhanced connectivity, the latest version of the Intelligent Radiation Therapy (iRT) software may facilitate improved workflow efficiencies with the planning, performance and reporting for radiation therapy.

The M-PRiSM risk stratification, which incorporates MRI features, offers a significantly higher C-index, one-year AUC and two-year AUC than the 8th AJCC staging system for predicting postoperative survival for patients with pancreatic ductal adenocarcinoma.

PSMA PET offered 18 percent higher accuracy for detecting biochemical recurrence of PCa in contrast to mpMRI, according to findings from a 67-study meta-analysis.

Expanded capabilities with the body composition analysis software include automated segmentation of over 140 muscles, skeletal and organ structures from a 15–20-minute MRI.

Offering prospective SNR calculation derived from prescribed slices, the SNR Calculator reportedly facilitates a higher degree of accuracy with quantitative SNR values beyond that of calculators from device manufacturers.

Catch up on the top radiology content of the past week.

Abbreviated biparametric MRI demonstrated nearly equivalent detection rates for clinically significant and clinically insignificant prostate cancer as multiparametric MRI, according to research involving 22 centers in 12 countries.

The AI-powered Tempus Pixel software update provides T1 and T2 inline maps to augment cardiac MRI assessment.

For HER2-positive breast cancer patients with radiologic complete response on breast MRI after neoadjuvant chemotherapy (NAC), the absence of calcifications was associated with over a 13 percent higher positive predictive value (PPV) for pathologic complete response (pCR).

Circumferential aneurysm wall enhancement on MRI was associated with a 3.8-fold higher risk of intracranial aneurysm instability within a four-year period, according to a study involving over 1,350 patients.

Catch up on the top radiology content of the past week.

For myocardial extracellular volume quantification, single-phase and dual-phase photon-counting CT provided over 20 percent higher correlation with cardiac MRI in contrast to dual-phase energy-integrating detector CT, according to new research findings.

In a 10-study meta-analysis examining the use of whole-body MRI for asymptomatic individuals, researchers noted a pooled cancer detection rate of 1.57 percent.

From emerging research on disparities in breast cancer screening to the promising combination of contrast-enhanced mammography with DBT and a three-part podcast on abbreviated breast MRI, here is a look back at the most well-reviewed breast imaging content of the summer.

Catch up on the most-well viewed radiology content in August 2025.

Catch up on the most-well viewed prostate imaging content in August 2025.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

In a new review of MRI-based scoring systems for T-staging of prostate cancer, researchers discuss key literature findings and principles in evaluating the extent of prostate cancer (PCa) lesions, and whether a focus on specificity could enhance the staging of PCa.

In the second part of a recent interview, Tammie Benzinger, M.D., Ph.D., discusses recently presented research from the Alzheimer’s Association International Conference (AAIC) that showed the ability of portable low-field MRI to detect mild and moderate amyloid-related imaging abnormalities (ARIAs).